CSPC 2018 has ended
Wednesday, November 7 • 3:30pm - 5:00pm
(90 min) Bringing Innovative Medicines into the Hands of Patients with Alzheimer's disease

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Organized by: Hoffmann-La Roche Ltd.

In 2016, an estimated 747,000 Canadians were living with Alzheimer’s Disease (AD) and related dementias. It is estimated that by 2030, 1.4 million Canadians will have AD or related dementias, an increase of 66 percent. By 2050, that number will increase to 2.8 million. As in other major markets, this rapidly increasing prevalence of people with AD and dementia is a significant concern to policymakers who are exploring how they can best support patients with AD and related dementia and their loved ones.
Recognizing the significant need and their commitment to improving the lives of Canadians with dementia, the Government of Canada announced in May 2018 that it was moving forward with a National Dementia Strategy. The Strategy will consider the experience of those living with dementia and will build on existing working being undertaken across Canada in this area. The Strategy poses a unique opportunity to define what is required from a healthcare system readiness perspective. 

The objective of the panel will be to explore the current work being undertaken by the Government of Canada to improve the regulatory and healthcare environment in order to bring innovative therapies into the hands of patients. The panel discussion is meant to ignite public policy discourse related to:
  • Current state of affairs in Canada and what is required from a healthcare readiness perspective in order to positive impact the lives of patient living with AD and their caregivers
  • Understand the current regulatory and market access decision making process and the gaps that exist in bringing innovative diagnostics and therapies to market in the area of Alzheimer’s Disease
  • Existing healthcare system gaps and existing opportunities to bridge those gaps

avatar for Soeren Mattke (MD, DSc)

Soeren Mattke (MD, DSc)

Senior Scientist at USC and the Director of the Center for Improving Chronic Illness Care
Soeren Mattke (MD, DSc) is a Senior Scientist at USC and the Director of the Center for Improving Chronic Illness Care. Dr. Mattke is an expert in innovations to prevent, diagnose and manage chronic disease via better drugs, devices and technologies, improved delivery models and value-based... Read More →

avatar for Christin Bexelius

Christin Bexelius

Doctor Christin Bexelius has since 2015 been leading payer related activities to support Roche’s phase III clinical trial programs in Basel, Switzerland. Through her work she has been working close with both internal and external stakeholders in relation to access and policy, including... Read More →
avatar for Andrew R. Frank M.D. B.Sc.H. F.R.C.P.(C)

Andrew R. Frank M.D. B.Sc.H. F.R.C.P.(C)

Cognitive and Behavioural Neurologist; Medical Director, Bruyère Memory Program, Élisabeth Bruyère Hospital
Dr. Andrew Frank is a cognitive and behavioural neurologist, and is the medical director of the Bruyère Memory Program at the Élisabeth Bruyère Hospital in Ottawa, Ontario.After finishing his Bachelor’s degree in Honours Biochemistry at the University of Calgary, Dr. Frank completed... Read More →
avatar for Dr. K. Jennifer Ingram MD, FRCPC

Dr. K. Jennifer Ingram MD, FRCPC

Founder, Medical Director and Qualified Investigator at the Kawartha Centre – Redefining Healthy Aging
Dr. Ingram earned her medical degree from Queen’s University and is a specialist in Internal and Geriatric Medicine, practicing in Peterborough, Ontario. She is the Founder, Medical Director and Qualified Investigator at the Kawartha Centre – Redefining Healthy Aging, a community-based... Read More →
avatar for Pauline Tardif

Pauline Tardif

Chief Executive Officer, Alzheimer Society of Canada
Pauline Tardif is the Chief Executive Officer of the Alzheimer Society of Canada. Pauline co-chairs the federal Ministerial Advisory Board on Dementia established by the Minister of Health in 2018. The Advisory Board is providing evidence-informed advice on current and emerging issues... Read More →

Wednesday November 7, 2018 3:30pm - 5:00pm EST
Delta Ottawa - Chaudière

Attendees (4)